Crescita Therapeutics Inc. (CRRTF,CTX.TO), on Wednesday, reported profit in the third quarter compared with loss in the previous year.
For the third quarter, net income came in at $0.75 million compared with loss of $1.04 million in the previous year.
Earnings per share were $0.04 versus loss per share of $0.05 last year.
Adjusted EBITDA came in at profit of $0.26 million compared with $681 million in the prior year.
Operating loss narrowed to $0.16 million from $1.17 million in the previous year.
Revenue increased to $5.39 million from $3.59 million in the previous year.
On Monday, Crescita Therapeutics closed trading at CAD 0.4400 on the Toronto Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.